Age‐related Macular Degeneration Market Growth Driven by Aging Population, Estimated $10.3 Billion in 2024 - DhananjayPinge/technoresearch GitHub Wiki
Age-related Macular Degeneration (AMD) is a progressive eye disorder that primarily affects individuals over the age of 50. It damages the macula, the central part of the retina responsible for sharp, straight-ahead vision. AMD is one of the leading causes of vision loss worldwide, significantly impacting the quality of life of patients. It is broadly categorized into two types: dry AMD, which progresses slowly, and wet AMD, which is less common but more severe and accounts for the majority of vision loss cases.
Download Free Sample Report with Full TOC & Graphs @ https://www.econmarketresearch.com/request-sample/EMR00481
Market Overview
The global Age-related Macular Degeneration (AMD) market is experiencing significant growth, fueled by an aging population, advancements in diagnostic technologies, and the introduction of innovative treatment options such as anti-VEGF therapies and gene-based treatments. With the rising prevalence of chronic conditions such as diabetes and hypertension, the number of individuals at risk of AMD continues to rise. Additionally, growing awareness about early detection and the expansion of healthcare infrastructure in emerging economies are creating a favorable market environment.
Market Value
In 2024, the global AMD market is estimated to be valued at USD 11.5 billion and is projected to reach approximately USD 17.2 billion by 2032, growing at a compound annual growth rate (CAGR) of around 5.1% during the forecast period. The consistent demand for effective treatment options, combined with ongoing R&D investments, is expected to drive sustained growth.
Market Opportunity
The AMD market presents substantial opportunities due to advancements in biologics, stem cell therapy, and personalized medicine. Increasing clinical trials for novel drug candidates and the adoption of AI-driven diagnostic imaging solutions are reshaping the treatment landscape. Moreover, the high unmet need in the dry AMD segment, which currently lacks effective therapies, offers significant potential for pharmaceutical companies. Collaborations between research institutes, biotech firms, and healthcare providers are also expected to accelerate the development of innovative treatment pathways.
Market Restraints
Despite its growth prospects, the AMD market faces several challenges. The high cost of treatment, especially anti-VEGF injections, limits accessibility for many patients in low- and middle-income countries. Moreover, limited availability of curative therapies for dry AMD and stringent regulatory processes pose hurdles for new product approvals. Patient adherence to frequent intravitreal injections also remains a key concern for long-term management.
Market Segmentation
By Type: Dry AMD, Wet AMD By Drug Class: Anti-VEGF drugs, Photodynamic therapy, Others By Route of Administration: Intravitreal injections, Oral, Others By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers Regional Analysis
North America: Dominates the AMD market due to advanced healthcare infrastructure, high adoption of innovative therapies, and strong presence of key players. Europe: Holds a significant share, supported by rising geriatric populations and government-funded research programs. Asia-Pacific: Expected to witness the fastest growth, driven by increasing awareness, a rapidly aging population, and expanding healthcare facilities in countries like China, India, and Japan. Latin America & Middle East & Africa: Emerging markets with growing potential, though challenges like limited access to advanced therapies and economic constraints may restrict growth. The Age-related Macular Degeneration market is set to expand steadily, backed by innovation, increased awareness, and rising demand for effective treatments. While challenges remain in affordability and accessibility, ongoing advancements in biologics, AI-based diagnostics, and regenerative medicine are expected to redefine patient care in the coming years.
Click Here for More Information About This Study @ https://www.econmarketresearch.com/industry-report/age-related-macular-degeneration-amd-market/
About Us:
At ECON Market Research, we specialize in delivering in-depth, data-driven insights to empower strategic decision-making across global industries. With a commitment to accuracy, integrity, and actionable intelligence, we provide market research reports, custom studies, and consulting services that help businesses navigate evolving market landscapes. Our team of experienced analysts and industry experts covers a wide range of sectors including healthcare, chemicals, logistics, energy, manufacturing, and advanced technologies.
Contact us:
Age-related Macular Degeneration Market
#AgeRelatedMacularDegeneration, #AMDMarket, #OphthalmologyMarket, #RetinalDisorders, #VisionCareIndustry